Elecsys® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathologyNow available nationwide in ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Workers across the Greater Lowell area are bracing for job cuts at labs and factories, as fresh state notices and company filings put well over a hundred local positions on the chopping block. The ...

Archimed, Astorg, HCAP and Salt Creek Capital are among the PE firms investing in the medical laboratory sector.

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and then move the technology into other facilities.

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

Maze Therapeutics (NASDAQ:MAZE) is advancing a genetics-driven approach to drug development, using human genetic analyses to identify gene variants linked to disease and then applying those insights ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

By Kamal Choudhury Feb 9 (Reuters) - Privately held Iambic said on Monday it has entered a multi-year partnership worth more than $1.7 billion with Japan's Takeda Pharmaceutical to use artificial ...

By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has ...